camptothecin has been researched along with galactose in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Beeser, A; Chernoff, J; Cotteret, S; Jaffer, ZM | 1 |
| Blanchard-Desce, M; Brevet, D; Da Silva, A; Durand, JO; Gallud, A; Garcia, M; Gary-Bobo, M; Hocine, O; Loock, B; Maillard, P; Maynadier, M; Mir, Y; Mongin, O; Morère, A; Raehm, L; Richeter, S; Rouxel, C | 1 |
| Dongbang, S; Jeon, HM; Jung, HS; Kang, C; Kim, JS; Lee, H; Na, YC; Shin, JW; Uhm, S | 1 |
| Cao, H; Liu, L; Wang, C; Zhang, W | 1 |
| Ding, R; Li, Z; Wang, J; Wang, M; Zhao, Z; Zhu, X | 1 |
| Chakraborty, K; Dhara, S | 1 |
| Kletzien, RF; Perdue, JF | 1 |
| Fang, XL; Li, JC; Sha, XY; Zhang, LJ | 1 |
8 other study(ies) available for camptothecin and galactose
| Article | Year |
|---|---|
p21-Activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD.
Topics: Animals; Apoptosis; Camptothecin; cdc42 GTP-Binding Protein; Cell Survival; CHO Cells; COS Cells; Cricetinae; Cyclic AMP-Dependent Protein Kinases; DNA, Complementary; Electrophoresis, Polyacrylamide Gel; Galactose; Genetic Complementation Test; Glutathione Transferase; Immunoblotting; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase Kinases; Microscopy, Fluorescence; Mitochondria; Models, Biological; Mutation; p21-Activated Kinases; Phosphorylation; Plasmids; Precipitin Tests; Protein Binding; Protein Serine-Threonine Kinases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sphingosine; Subcellular Fractions; Transfection | 2003 |
Multifunctionalized mesoporous silica nanoparticles for the in vitro treatment of retinoblastoma: Drug delivery, one and two-photon photodynamic therapy.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Line, Tumor; Drug Carriers; Endocytosis; Galactose; Humans; Mannose; Nanoparticles; Photochemotherapy; Retinal Neoplasms; Retinoblastoma; Silicon Dioxide | 2012 |
HepG2 Cell Resistance against Camptothecin from a Lysosomal Drug Delivery.
Topics: Antineoplastic Agents, Phytogenic; Camptothecin; Cell Survival; Drug Carriers; Galactose; Hep G2 Cells; Humans; Lysosomes; Microscopy, Confocal; Spectrometry, Fluorescence | 2015 |
Intracellular GSH-activated galactoside photosensitizers for targeted photodynamic therapy and chemotherapy.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Galactose; Glutathione; Humans; Light; Micelles; Molecular Structure; Photochemotherapy; Photosensitizing Agents; Structure-Activity Relationship; Surface-Active Agents; Tumor Cells, Cultured | 2017 |
Design and Synthesis of Galactose-Biotin Lipid Materials for Liposomes to Promote the Hepatoma Cell-Targeting Effect.
Topics: Antineoplastic Agents; Asialoglycoprotein Receptor; Biotin; Camptothecin; Carcinoma, Hepatocellular; Drug Carriers; Drug Liberation; Drug Screening Assays, Antitumor; Galactose; Hep G2 Cells; Hepatocytes; Humans; Lipids; Liposomes; Liver Neoplasms; Particle Size | 2019 |
Apoptotic effect of sulfated galactofucan from marine macroalga Turbinaria ornata on hepatocellular and ductal carcinoma cells.
Topics: Apoptosis; Camptothecin; Carcinoma, Ductal; Carcinoma, Hepatocellular; Fucose; Galactose; Hep G2 Cells; Humans; Isothiocyanates; Liver Neoplasms; Phaeophyceae; Polysaccharides; Seaweed; Sulfates; Tumor Suppressor Protein p53 | 2022 |
Regulation of sugar transport in chick embryo fibroblasts and in fibroblasts transformed by a temperature-sensitive mutant of the Rous sarcoma virus.
Topics: Animals; Avian Sarcoma Viruses; Biological Transport, Active; Blood; Camptothecin; Carbohydrate Metabolism; Cell Transformation, Neoplastic; Chick Embryo; Culture Media; Culture Techniques; Cycloheximide; Dactinomycin; Deoxyadenosines; Fibroblasts; Hexoses; Mutation; Temperature | 1976 |
[9-nitrocamptothecin nanostructured lipid carrier system: in vitro releasing characteristics, uptake by cells, and tissue distribution in vivo].
Topics: Animals; Antineoplastic Agents; Camptothecin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Female; Hexoses; Liver; Lung; Macrophages, Peritoneal; Mice; Nanoparticles; Particle Size; Phagocytosis; Phosphatidylcholines; Polyethylene Glycols; Tissue Distribution | 2005 |